Natixis’s Avanos Medical AVNS Stock Holding History

Natixis’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-8,287	Closed	-$408K	–	365
2015 Q1	$408K	Hold	8,287	–	–	0.01%	320
2014 Q4	$377K	Buy	+8,287	New	+$326K	0.01%	311

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

RR Partners New York $929M AUM 110.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Natixis's AVNS Position: Q2 2015 in Review

Natixis sold out of Avanos Medical (AVNS) in Q2 2015, closing a stake of 8,287 shares — an estimated $408K sold.

Natixis first reported a position in AVNS in Q4 2014 and held it in 2 quarters. The position peaked at $408K in Q1 2015. 419 funds tracked by Wall St. Rank hold AVNS as of Q2 2015.

Natixis reported no remaining Avanos Medical position as of Q2 2015 after selling out during the quarter.
Natixis sold 8,287 Avanos Medical shares in Q2 2015, an estimated $408K.
Natixis first reported a position in Avanos Medical in Q4 2014 and held it in 2 quarters.
Natixis's Avanos Medical position peaked at $408K in Q1 2015.
419 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2015.

Based on Natixis's 13F filing for Q2 2015, filed 14 Aug 2015.